BALCHEM CORP — Director's Dealing 2021

Feb 17, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BALCHEM CORP (BCPC)
CIK: 0000009326
Period of Report: 2021-02-11

Reporting Person: Hyde James C (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6310	Direct
Common Stock	7660	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$60.85	2026-02-23	Common Stock (18000)		Direct
Employee Stock Option (right to buy)	$85.4	2027-02-21	Common Stock (5660)		Direct
Employee Stock Option (right to buy)	$74.57	2028-02-15	Common Stock (3800)		Direct
Employee Stock Option (right to buy)	$84.09	2029-02-13	Common Stock (4000)		Direct
Employee Stock Option (right to buy)	$111.94	2030-02-13	Common Stock (4700)		Direct
Employee Stock Option (right to buy)	$119.13	2031-02-11	Common Stock (3300)		Direct

Footnotes

F1: Ownership consists of 790 shares held in Reporting Person's Company 401(k)/profit sharing plan account and 5,520 shares held directly

F2: Ownership of restricted stock vests in Reporting Person 3 years following the grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.

F3: Options vest 20% year 1; 40% year 2; and 40% year 3